Tag | Content |
---|
EnhancerAtlas ID | HS020-19471 |
Organism | Homo sapiens |
Tissue/cell | CD34+ |
Coordinate | chr17:58512820-58515330 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr17:58514893-58514914 | CTAAAGTTTTACTTTCAGTTT | + | 6.48 | IRF1 | MA0050.2 | chr17:58514899-58514920 | TTTTACTTTCAGTTTTTTTTG | + | 7.78 | NEUROG2 | MA0669.1 | chr17:58514251-58514261 | GACATATGTT | - | 6.02 | Nr2f6(var.2) | MA0728.1 | chr17:58514562-58514577 | CGAACTCTTGACCTC | - | 6.24 | REL | MA0101.1 | chr17:58514769-58514779 | GGAAATCCCC | - | 6.02 | TFAP2A | MA0003.3 | chr17:58512987-58512998 | TGCCTGAGGCA | - | 6.02 | Zfx | MA0146.2 | chr17:58515150-58515164 | CCCGCCTCGGCCTC | + | 6.01 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr17 | 58512988 | 58513661 | chr17 | 58514180 | 58514329 |
|
| Number: 2 | ID | Chromosome | Start | End |
GH17I060435 | chr17 | 58512917 | 58514010 | GH17I060437 | chr17 | 58514562 | 58515161 |
|
Enhancer Sequence | GAGACGTAGG CACTGGGCGC AGGATGCAGC GGCGCGCGGG CTTTGCTCGG TTCGGGGATC 60 GTTCTCGCCT CTTCTTCCTC CAAATTTTGT GAACTTTTAT CATTTCCAGG AGGGTAAGTA 120 GGTCCAAACA TTCCCCAAAA ACACAAATGA CATATTTTCC AGGGCTCTGC CTGAGGCAGC 180 AGCATATAGG GTGCAGGGCT GCCCTGGAGC AGGAGAGGCC AGGGCAGATG TGTGTGACTC 240 TTCTCCCTCC CTCCCTCGAT TTGTGTTCAG AAGTAAGTAT CGTCATAGAC TGACAAGGCT 300 AAAATGAATA TCAATCTAGT CTCGAAGAAG GAGTTCAGGG AAGCATGAAT GGGGGAAGCG 360 GGGAGGAAGC GCCATTTCTT TCCTCCTTAG AGTCATCGCC TCCTGGAAGT GGCAAGATGA 420 GACGGCCAAG GCATAGGCCT GGGGCCAGCC TGGCTTGGCT AGACCCTGAC AGTTTTGTCA 480 AAGCAGGGAG GATTTCAGAG AGAAGGGAAG CCGGGCTGGA GGGTGTCCAT GATGACTATG 540 GGCTTTCCAA TGTTTTCTAC TCCTAAGAGA TTTCAGAAAT GTGGCTGTTT TGGGAACAGT 600 CCAAAAACAC GAAGTATCCC CAGTAGTCAA GGCAGCACTG CCACCTAGAG GAATTGTGAG 660 ACACTACAGC CTTGTTCTTT CAACCAACAT GTGCAAACCA GCGTGTGCAA AAGATGAAGA 720 TGAGAGAAGG GAGCCAGGGG TTCGTTTATC AACCTTGAGA ACAATCGGGA CGCATAAAGG 780 CAAAAATGGA CAACAAGTGA GGCTTGGTTT TGAAGCTTTC TTTCTTTCTT TTTTCCTTAG 840 ACGGAATCTC GCTCTGTCGC CCAGGCTGGA GTGCAATGGC GCAGTCTCGG CTCACTGCAA 900 CCTCCGCCTC CCGGGTTCAA GCGATTCTCC TGCCTCAGCC TCCCAGGTAG CTGGGCTTAC 960 AGGAGCGCGC CACCAAGCCT GGCTAATTTT TTTGTATTTT CAGTAGAGAC GGGGTTTCAC 1020 CATGTTGTCC AGGCTGGTCT CAAACTCCGC TGGCCTCCGC CTACCAAAGT GCTGAGATTA 1080 CAGGCGTGAG CCACCACACC CGGTCAATTA TTGTATTTCT TGTTTATTAA CTGTCTTCTT 1140 CCCTTAGAAT GTAAGTTCCA CAGGGTTAGA GATTTTTGTC TGTCCTGTTC ATTGCTGTAT 1200 CCAAAGCAAT TACAATAGTA TTCAACATAT AATAGGTACT TAGCAAACTT TTAATGAATG 1260 AACCAACCCA AAACAGAGAA TTCTGACCAA CCACCTCCTC GTTCAGAGGG GAAAACAGAG 1320 GCCCAAGAAG AAAGGCGACT TCTCCAAGGT TGTGCAGGAA GTCAATGGCA GAACTGGAAC 1380 GACAACTCAG ACCTGAGGTC CCCCAGGCCA GCGCACTTCC TACATACCAA CGACATATGT 1440 TTCACCTACT CTTGGCCCAC ACACTCATTT CTCACAAGAT AGAAATAACC CTCAAGACTA 1500 AAATGTATTA CTTCTTCTCC TTCTTCTTCT TCTTTTTTTT TTTTAAGACA GTCTCACTCT 1560 GTCACCCAGG TTGGAGTGTA GTGGTGCAAT CTCCACTCAC CACAACCTCT GCCTCCCGGG 1620 TTCAAGCGAT TCTCCTGCCC TATCTCCAGA GTTGCTGGGA TTACAGGCGC CCGCCACCAC 1680 GCCCAGCTAA TTTTTGTATT TTTAGTAGAG ATGGGGTTTC ACCATGTTGT CCAGGCTGGT 1740 CTCGAACTCT TGACCTCAGG TGATCCGCCC ACCTCAGCCT CCCAAAGTGC TGGGATTACA 1800 GGCATTAGCC ACTGCGCCTA ACCAAAATGT ATTACTTCTT CTAGAATTTT TATTTTTTAA 1860 AAGTATCTCT ACCCAAAAGT ATAATGGTGG ACTTGGGAAC ACCAGAAACA GGTTGTTGGA 1920 GAGGCTATTG GGAAGTGGGG AGCCTTGGTG GAAATCCCCA AATCATACCT TGGCCTATGC 1980 TGCCTTAGGG GTGAGGCTCA TCCTAGAGAA AGTGCCTCAC TATCGGAGCC TTCGAGAAGG 2040 GTCCTTTTCC TTAGAGAATA AAGGGTACTT TCCCTAAAGT TTTACTTTCA GTTTTTTTTG 2100 TTTTTTTTTT TTGAGACGGA GTCTCTGTCA CCCAGGCTGG AGTGCAGTGG CGCAATCTTG 2160 GCTCACTGCA AGCTCCGCCT CCCGGGTTCA CGCCATTCTC CTGCCTCAGC CTCCAGAGTA 2220 GCTGGGACTA CAGGCGCCCA ATGGTGCCCG GCTAATTTTT GTATTTTTAG TAGAGACGGG 2280 GTTTCACCGT GTTAGCCAGG ATGGTCTCAA TCTCATGACC TCGTGATCCA CCCGCCTCGG 2340 CCTCCCAAAG TGCTGGGATT ACAGGCTTGA GCCACCGTGC CCAGCTGTTT CCTGACTTTT 2400 TAATGATCGC CATTCTAACT GGTGTGAGAT GGTATCTCAT TGTGGTTTTG ATTTGCATTT 2460 CTCTGATGGC CAGTGATGAT GAGCATTTTT TCATGTGTTT TTTGGCTGCA 2510
|